Skip to main content

Biotech Stocks Will Likely Be Very Bullish in 2018, This is Why

As biotech is a very risk sensitive asset, and as sellers seem to lose control, we believe the second half of 2018 will start with a bullish breakout which will be confirmed once the IBB ETF rises above 120 points.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.